Skip to content

Effect of thoracic epidural analgesia and intravenous analgesia on Acute and Chronic pain after thoracic surgery

Effect of thoracic epidural analgesia and intravenous analgesia on Acute and Chronic pain after thoracic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021826
Enrollment
Unknown
Registered
2019-03-11
Start date
2019-03-15
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Epidural analgesia group:0.125%ropivacaine and 0.5ug/ml sufentanil
intravenous analgesia group:1.5ug/ml sufentanil

Sponsors

General Hospital of Southern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. American Society of Anesthesiologists physical status class I - III; 3. Be able to use intravenous analgesia pump.

Exclusion criteria

Exclusion criteria: 1. With history of long-term chronic pain; 2. With history of long-term use of opioid analgesics; 3. abnormal lung function before surgery; 4. Narcotic drug allergy history; 5. Patients are reluctant to participate in the experiment; 6. The patient who cannot communicate because of coma, severe dementia, or speech disorder; 7. severe liver, brain and kidney disease; 8. Severe pulmonary dysfunction in patients; 9. Long-term use of opioid analgesics and long-term alcohol abuse history, history of mental illness and depression; 10. Excessive anxiety, nervousness before surgery; 11. There epidural analgesia contraindication; 12. Postoperative deterioration.

Design outcomes

Primary

MeasureTime frame
numerical rating scale;verbal rating scale;The incidence of chronic pain;The time of first ambulation;

Secondary

MeasureTime frame
Times of analgesia pump;Supplementary analgesia;Sedation scores;Supplementary Antiemetic;Pruritus;Nausea and vomiting;Hypotension;Respiratory depression;Other adverse reactions;

Countries

China

Contacts

Public ContactTu Weifeng

General Hospital of Southern Theater Command

wftuyx02@163.com+86 13922116606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026